Table 2 Patients’ characteristics
Variables | PMT group (n = 30) | Non-PMT group (n = 64) | P |
|---|---|---|---|
Age [year] | 68.5 (51–86) | 65.0 (43–78) | 0.071 |
Gender (male/female) | 23/7 | 57/7 | 0.131 |
Location of tumor, n (%) | 0.413 | ||
Ut | 6 (20.0) | 6 (9.4) | |
Mt | 13 (43.3) | 36 (56.2) | |
Lt | 9 (30.3) | 16 (25.0) | |
Ae | 2 (6.7) | 6 (9.4) | |
cStage (UICC 7th), n (%) | 0.153 | ||
I | 5 (16.7) | 25 (39.1) | |
II | 10 (33.3) | 14 (21.9) | |
III | 12 (40.0) | 20 (31.2) | |
IV | 3 (10.0) | 5 (7.8) | |
Neoadjuvant chemotherapy, n (%) | 14 (46.7) | 26 (40.6) | 0.652 |
Neoadjuvant chemoradiotherapy, n (%) | 6 (20.0) | 5 (7.8) | 0.099 |
Salvage operation, n (%) | 1 (3.3) | 4 (6.3) | 1.000 |
Preoperative pulmonary function | |||
VC [L] | 3.51 (2.03–5.43) | 3.66 (2.05–5.57) | 0.113 |
%VC | 114 (67–134) | 110 (76–166) | 0.703 |
FEV1.0 [L] | 2.41 (1.11–3.36) | 2.68 (1.59–4.13) | 0.035 |
FEV1.0% | 71.5 (53.2–91.3) | 76.4 (60.2–93.8) | 0.160 |
FEV1.0% < 60%, n (%) | 4 (13.3) | 0 | 0.009 |